Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsatypical hemolytic uremic syndrome・thrombotic microangiopathy・complement inhibition・eculizumab・C3 glomerulopathy・anti-GBM disease・renal pathology・calcimimetics

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Fatal Eosinophilia-Associated Thrombotic Microangiopathy and the Role of Renal Charcot-Leyden Crystals.2025
• Atypical hemolytic uremic syndrome treated with anti-C5 antibody agent eculizumab, without genetic complement abnormalities.2025
• Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review
• Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist

• Official profile